Propofol Market Analysis

  • Report ID: 3132
  • Published Date: Sep 02, 2024
  • Report Format: PDF, PPT

Propofol Market Analysis

The propofol market is segmented by application into procedural sedation and general anesthesia, out of which, the general anesthesia segment is estimated to hold a significant market share on the back of rising number of surgical procedures across the globe coupled with the easy availability of the drug. As per the U.S. National Institutes of Health, every day about 60,000 people in the nation undergo surgery under general anesthesia. Apart from this, the ability of anesthesia to enable painless medical procedures that lead to healthier and longer lives is also evaluated to boost growth of this market segment in the future. Additionally, on the basis of distribution channel, the segment for hospitals is expected to garner the largest market share over the forecast period, which can be ascribed to the high number of admissions and abundant availability of appropriate medical equipment in a hospital facility. 

Our in-depth analysis of the global propofol market includes the following segments

 

By Application

  • Procedural Sedation
  • General Anesthesia

      

By Distribution Channel

  • Ambulatory Surgery Centers
  • Ophthalmic Clinics
  • Hospitals
  • Dental Clinics
  • Specialty Clinics

By End-user

 

  • Seditionist
  • Anesthesiologist
  • Others
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3132
  • Published Date: Sep 02, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of propofol is evaluated at USD 1.03 billion.

Propofol Market size was over USD 989.4 million in 2023 and is poised to cross USD 1.91 billion by 2036, growing at more than 5.2% CAGR during the forecast period i.e., between 2024-2036. High influence of propofol on the anesthesia practice and rise in the number of surgical procedures will propel the market growth.

North America is poised to account for largest revenue share by 2036, on the back of increase in the number of well-established healthcare facilities, high adoption of minimally invasive surgical procedures and easy availability of drugs in the region.

The major players in the market are Pfizer Inc., Bachem Holding AG, Porton Fine Chemicals Ltd., SI Group, Inc., AstraZeneca plc, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample